Improved barrier function and stool consistency
In an eight-week randomized, placebo-controlled trial published in 2019, adults with post-infectious IBS with diarrhea and increased intestinal permeability received glutamine or placebo. In the glutamine group, permeability normalized, average bowel movements fell from 5.4 to 2.9 daily, and stools became more formed. Improvements exceeded placebo. This supports a connection in this specific diarrhea population, not proof of constipation relief.












